Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideMRKMerck & Co.
FinDog View：Neutral
ZBHZimmer Biomet
FinDog View：Neutral
| Metric | MRK | ZBH |
|---|
| Close | 144.91 | 96.78 |
| Market Cap | $358B | $18.4B |
| 1M | +6.57% | −1.45% |
| P/E (TTM) | 112.2 | 22.1 |
| Forward P/E | 19.5 | 10.8 |
| P/E 5-Yr Percentile | 81 | 25 |
| P/S | 5.4 | 2.1 |
| P/B | 8.5 | 1.4 |
| Dividend Yield | 2.87% | 1.04% |
| Latest Quarter Revenue | $16.6B | $2.2B |
| Revenue YoY | +5.1% | +4.8% |
| Gross Margin | 73.5% | 70.8% |
| Latest Quarter EPS | -0.54 | 1.03 |
| Avg Post-Earnings Move | ±1.7% | ±2.1% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 3.50% | 5.11% |
| 90-Day Net Insider Buying | −$30.0M | −$0.82M |
MRK · Revenue, Last 8 Quarters ($B)
ZBH · Revenue, Last 8 Quarters ($B)
